Kinase, in vitro: 

An enzyme-substrate reaction that occurs in non-living experimental conditions such as a test tube. For example, a purified enzyme is reacted with a substrate protein or mixture of proteins or peptides.

CDK1 S613-p
HGK T1079-p
NuaK1 S464-p
 Putative in vivo kinases: 

An enzyme-substrate reaction that occurs within living cells; includes cultured cells, ex vivo samples, and intact organisms. In the case of kinases, the large number of protein kinases in intact cells makes exact identification of the responsible kinase challenging.

CDK1 T490-p , S613-p
GCK T1079-p
HGK T1079-p
LATS1 S674-p , S909-p , S1049-p
MINK T1079-p
MST1 T1079-p
MST2 S872-p , S909-p , T967-p , T1012-p , T1060-p , T1079-p
NuaK1 S464-p
NuaK2 S464-p
TAO1 T1079-p
Regulatory protein:
COL4A1 S909-p
FAM40B T1079-p
FRK S909-p , T1079-p
FRMD6 S909-p
GRF-1 S909-p
KIBRA T1079-p
LATS1 S909-p , T1079-p
LKB1 T1079-p
MARK4 T1079-p
Merlin T1079-p
MST1 T1079-p
MST2 T1079-p
PFKFB3 T1079-p
PPP2CA T1079-p
RAB11A S872-p , S909-p , T1079-p
SLMAP T1079-p
STRIP1 T1079-p
WWC2 T1079-p
WWC3 T1079-p
Treatment:
2-deoxyglucose S909-p , T1079-p
angiotensin_2 S464-p
AZD1152 S464-p
BI2536 S42-p , S464-p
Ca(2+) S909-p , T1079-p
calmodulin S909-p , T1079-p
CAY10594 S909-p
Cd(2+) S909-p , T1079-p
CI 976 S909-p
Clostridium perfringens enterotoxin T1079-p
CNO S909-p , T1079-p
Diacylglycerol_Kinase_inhibitor_I S909-p
DLGAP1 S909-p
doxycycline T1079-p
ephrin_B1 Y283-p
FGF2 S909-p , T1079-p
FIPI S909-p
glomerular antiserum S909-p
glucose_starvation K860-ub
high_cell_density T1079-p
ischemia S177-p
lncRNAs S909-p
LPA T1079-p
MG132_withdrawal T246-p , S464-p , S613-p
miRNA T1079-p
nocodazole S613-p
okadaic_acid T1079-p
PA S909-p
PD98059 S909-p
PFK158 T1079-p
phenformin S909-p
serum T1079-p
serum_starvation S909-p , T1079-p
siRNA K751-sm , K860-ub
stiff ECM substrate T1079-p
U0126 S909-p
U73122 T1079-p
virus infection S909-p , T1079-p
XMU-MP-1 T1079-p
Y15 S909-p
Y27632 T1079-p
ZM447439 S464-p
Zn(2+) S909-p , T1079-p